文献速递皮肤肿瘤

非黑色素瘤皮肤癌作为内脏恶性肿瘤的临床标志:全国性人群队列研究

Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-11-26

INTRODUCTION: Non-melanoma skin cancers (NMSCs) are the most common cancers in the world, but the risk of internal malignancy in patients with NMSC has not been well investigated.…

要点

  • NMSC患者内脏恶性肿瘤总体风险显著升高(HR 1.866)。
  • 骨癌、鼻腔喉癌、口腔咽癌等风险升高超过5倍。
  • 结直肠癌风险显著降低(HR 0.765)。

核心结论

  • NMSC患者发生内脏恶性肿瘤的总体风险显著高于无NMSC的匹配对照。

主要发现

  • NMSC患者内脏恶性肿瘤总体发病率为2727.7/10万人年,对照组为1392.4/10万人年,HR 1.866(95%CI 1.768-1.970)。
  • 骨癌风险最高(HR 12.745,95%CI 6.288-25.834),其次为鼻腔和喉癌(HR 10.279,95%CI 6.178-7.103)、口腔和咽癌(HR 10.211,95%CI 7.375-14.137)、肛门和肛管癌(HR 8.147,95%CI 3.893-17.051)及宫颈癌(HR 5.900,95%CI 3.694-9.423)。
  • 胸部、食管、乳腺、肺、胃、甲状腺癌及非霍奇金淋巴瘤风险在NMSC患者中也显著升高。
  • 结直肠癌风险在NMSC患者中显著降低(HR 0.765,95%CI 0.657-0.890)。

临床怎么用

  • 对NMSC患者应进行仔细的内脏恶性肿瘤筛查和随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Non-melanoma skin cancers (NMSCs) are the most common cancers in the world, but the risk of internal malignancy in patients with NMSC has not been well investigated. OBJECTIVES: We aimed to assess the risk of internal malignancy in patients with NMSC compared with controls without NMSC in Korean population. METHODS: This nationwide cohort study, compared 27 259 NMSC patients with 54 518 matched controls without NMSC, 40 years or older using the data from Korea Health Insurance Review and Assessment Service from 2007 to 2016. The first 2 years were washout period, and we followed the patients for 8 years to observe the development of any internal malignancies after a diagnosis of NMSC. The Cox proportional hazard model was used to determine the hazard ratios (HRs) for developing internal malignancies. RESULTS: The overall risk of internal malignancies at all sites was 2727.7 and 1392.4 per 100 000 person-years for the patients with NMSC and controls, respectively. The risk was significantly higher in the patients with NMSC (HR 1.866, 95% confidence interval [CI] 1.768-1.970). Bone cancer showed the highest risk (HR 12.745, 95% CI 6.288-25.834), followed by nasal cavity and larynx (HR 10.279, 95% CI 6.178-7.103), oral cavity and pharynx (HR 10.211, 95% CI 7.375-14.137), anus and anal canal (HR 8.147, 95% CI 3.893-17.051) and cervical (HR 5.900, 95% CI 3.694-9.423) cancers with risks greater than fivefold higher in NMSC patients compared with the controls. The risks of cancers of the thorax, oesophagus, breast, lung, stomach, thyroid gland and non-Hodgkin's lymphoma were also statistically higher in the patients with NMSC. In contrast, the risks of cancers of the colon and rectum were found to be significantly decreased in the patients with NMSC (HR 0.765, 95% CI 0.657-0.890). CONCLUSION: Patients with NMSC require careful screening and follow-up for internal malignancy.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Yun SJ, Bae JM, Kim H, et al. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study. J Eur Acad Dermatol Venereol. 2019. PMID: 31494979. doi:10.1111/jdv.15936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。